Novo Nordisk (United Kingdom)

526 papers and 15.4k indexed citations i.

About

In recent decades, authors affiliated with Novo Nordisk (United Kingdom) have published 526 papers, which have received a total of 15.4k indexed citations. Scholars at this organization have produced 210 papers in Endocrinology, Diabetes and Metabolism, 152 papers in Molecular Biology and 115 papers in Genetics on the topics of Diabetes Treatment and Management (136 papers), Diabetes Management and Research (121 papers) and Metabolism, Diabetes, and Cancer (66 papers). Their work is cited by papers focused on Molecular Biology (5.1k citations), Endocrinology, Diabetes and Metabolism (4.8k citations) and Surgery (2.9k citations). Authors at Novo Nordisk (United Kingdom) collaborate with scholars in United Kingdom, Denmark and United States and have published in prestigious journals including Cell, Proceedings of the National Academy of Sciences and The Lancet. Some of Novo Nordisk (United Kingdom)'s most productive authors include Dipender Gill, Barrie Chubb, Stephen Burgess, Joanna M. M. Howson, David R. Owens, Susanna C. Larsson, Jens Brange, Aage Vølund, Steven Kang and Torsten Christensen.

In The Last Decade

Fields of papers published by authors at Novo Nordisk (United Kingdom)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novo Nordisk (United Kingdom) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novo Nordisk (United Kingdom) at the time of their publication.

Countries citing scholars working at Novo Nordisk (United Kingdom)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novo Nordisk (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novo Nordisk (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novo Nordisk (United Kingdom) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025